[1] Zerche M,Weissenborn K,Ott C,et al.Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke[J].Stroke,2015,46(5):1180-1186.DOI:10.1161/strokeaha.114.008323.
[2] Herz J,Sabellek P,Lane TE,et al .Role of neutrophils in exacerbation of brain injury after focal cerebral ischemia in hyperlip-i demic mice[J].Stroke,2015,46(10):2916-2925.DOI:10.1161/strokeaha.115.010620.
[3] Lagos J,ZambranoT,RosalesA,et al.ApoE Poly-morphisms contribute to reduced atorvastatin re-sponse in Chilean Amerindian subjects[j].Int J Mol Sci,2015,16(4):7890-7899.DOI:10.3390/ijms16047890.
[4] Toops K A,Tan L X,Lakkaraju A.Apolipoprotein E isoforms and AMD[J].Adv Exp Med Biol,2016,24(1):1-10.DOI:10.1007/978-3-319-17121-0_1.
[5] Ellulu M S,Patimah I,Khaza AI H,et al.Atherosclerotic cardiovascular disease:a review of initiator and protective factors [J].Inflammopharmacology,2016,24(1):1-10.DOI:10.1007/s10787-015-0255-y.
[6] Liu C-C,Kanekiyo T,Xu H,et al.Apolipoprotein E and Alzheimer disease:risk,mechanisms,and therapy[J].Nature reviews Neurology,2013,9(2):106-118.DOI:10.1038/nrneurol.2013.32.
[7] Baptista R,Rebelo M,Decqmota J,et al.Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and poorer response to lipid-low-ering therapy [J].Lipids Health Dis,2011,10(1):48.DOI:10.1186/1476-511x-10-48.
[8] Chasman D I,Giulianini F,Macfadyen J,et al.Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction:the Justification for the Use of Statins in Pervention:an Intervention Trial Evaluating Rosuvastatin(JUPITER)trial[J].Circulation Cardiovascular genetics,2012,5(2):257-264.DOI:10.1161/circgenetics.111.961144.
[9] Chamberlain AM,Agarwal SK,Folsom AR,et a1.Smoking and in—cidence of atrial fibrillation:results from the Athcroselerosis Risk in Communities(ARIC)study[J].Heart Rhythm, 2011,8(8):1160·1166.DOI:10.1016/j.hrthm .
[10] Suzuki S,Sagara K,Otsuka T,et a1.Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with speeial reference to sex differences[J].Circ J,2013;77(12):2948-2953.DOI:org/10.1253/circj.CJ-13-0446.
[11] Shinya Suzuki.“Cholesterol Paradox”in Atrial Fibrillation.Circulation Journal,2011,75:2749-2750.DOI:org/10.1253/circj.CJ-11-1134.
[12] Faye L.Lopez,Sunil K.Agarwal,Richard F.MacLehose,et al.Blood Lipid Levels,Lipid-Lowering Medications,and the Incidence of Atrial Fibrillation The Atherosclerosis Risk in Communities Study.Circ Arrhythm Electrophysiol.2012,5:155-162.DOI:10.1161/circep.111.966804.
[13] Vaarhorst AA,Beekman M,Suchiman EH,et al.Lipid metabolism in long-lived families:the Leiden Longevity Study[J].Age(Dordr),2011,33(2):219-227.
DOI:10.1007/s11357-010-9172-6.
[14] Sokal A,Wojcik S,Pruszkowska P,ett al.Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation-preliminary report[J].Postepy Hig Med Dosw(Online),2017,71(0):876-880.DOI:10.5604/01.3001.0010.5267.
[15] Hermida J,Lopez FL,Montes R,et al.Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation(from the Atherosclerosis Risk In Communities[ARIC]Study)[J].Am J Cardiol,2012,109(1):95-99.DOI:10.1016/j.amjcard.2011.08.010.
[16] Huebbe P,Lodge JK,Rimbach G.Implications of apolipoprotein E genotype on inflammation and vitamin Estatus[J].Mol Nutr Food Res.2010,54(5):623-630.DOI:10.1002/mnfr.200900398.
[17] Frustaci A,Chimentc C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation[J].Circulation,1997,96:1180-1184.DOI:10.1161/01.cir.96.4.1180.
[18] Hall G,Hasday J D,Rogers T B.Regulating the regulator:NF-κB signaling in heart[J].J Mol Cell Cardiol,2006,41(4):580-591.DOI:10.1016/j.yjmcc.2006.07.006.
[19] Jofre-Monseny L,Minihane AM,Rimbch G.Impact of ApoE genotype on oxidative stress,inflammation and disease risk[J].Mol Nutr Food Res,2008,52(1):131-145.DOI:10.1002/mnfr.200700322
[20] Stanley A,Masahide H.Atrail remodeling and atrial fibrillation [J].J Am Coll Cardiol,2014,63(22):2336-2344.DOI:10.1016/j.jacc.2014.02.555.
[21] Rodriguez-Rodriguez Luis, Gonzalez-Juanatey Carlos, Garcia-Bermudez Mercedes, et al. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. [J]Arthritis Res Ther. 2011;13(4):R133.DOI:10.1186/ar3444.
[22] Brundel BJ,Ausma J,Van Gelder IC,et al .Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation [J] .Cardiovasc Res,2002,54(2)380-389.DOI:10.1016/s0008-6363(02)00289-4.
[23] Peng B.Progress of Relationship Between Monocyte Chemotactic Protein.1 and Heart Failure[J].ADVANCES IN CARDIOVASCULAR DISEASES,2007,28(4)570-572.
[24] Damas JK,Aukrust P,Ueland T,et al.Monocyte chemoattractant protein-1 enhances and inter leukin-10 suppresses the production of inflammatory cytokines in adult rat card iomyocytes [J].Basic Res Cardiol,2001,96(5):345-352.DOI:10.1007/s003950170042
[25] Peng C,Ma YP,Wang J,et,al.Analyze the relationship between atrial fibrillation and plasma Mononuclear cells or cardiac function[J].Chongqing Medicine,2014,43(20):2589-2591.
[26] Liu JF,Ma HS,Li F.Correlation between ApoE gene polymorphism and lipid metabolism[J].Chinese Journal of Gerontology,2012,32(9):1802-1804.
[27] Canestaro WJ ,Brooks DG ,Chaplin D ,et al .Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testing.[J].J Pers Med ,2015,2(4):158-174.DOI:10.3390/jpm2040158.
[28] Chai YL,Yeo HK,Wang J,et al.Apolipoprotein varepsilon4 is Associated with Dementia and Cognitive Impairment Predominantiy Due to Alzheimer’s Disease and Not with Vascular Cognitive Impairment:A Singapore-Based Cohort [J].J Alzheimers Dis,2016,51(4):1111-1118.
[29] Hanh NTH,Nhung BT,Dao DTA,et al.Association of apolipoprotein E polymorphism with plasma lipid disorders,independent of obesity-related traita in Vietnamese children[J].Lipids Health Dis,2016,15(1):176.DOI:10.1186/s12944-016-0349-6.
[30] Farnaz A,Marcia LS,Elena SB,et,al.Obesity,physical activity,and their interaction in incident atial fibrillation in postmenopausal women[J].J Am Heart Assoc,2014,3:e001127.DOI:10.1161/jaha.114.001127.
[31]Torres-Perez E,Ledesma M,Garcia-sobrevielam P,et al.Apolipoprotein E4 association with metabolic syndrome dwpwnds on body fatness [J].Atherosclerosis,2016,245(1):35-42.DOI:10.1016/j.atherosclerosis.2015.11.029.